tradingkey.logo
搜索

Eikon Therapeutics Ord Shs

EIKN
添加自选
12.540USD
+0.290+2.37%
收盘 07/02, 13:00美东报价延迟15分钟
663.20M总市值
亏损市盈率 TTM

关于 Eikon Therapeutics Ord Shs 公司

Eikon Therapeutics Ord Shs简介

公司代码EIKN
公司名称Eikon Therapeutics Inc
上市日期Feb 05, 2026
CEOPerlmutter (Roger M)
员工数量384
证券类型Ordinary Share
年结日Feb 05
公司地址230 Harriet Tubman Way
城市MILLBRAE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编94030
电话13026587581
网址https://eikontx.com/
公司代码EIKN
上市日期Feb 05, 2026
CEOPerlmutter (Roger M)

Eikon Therapeutics Ord Shs公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
111.11K
+100.00%
,
,
--
--
Dr. Alfred Bowie, Ph.D.
Dr. Alfred Bowie, Ph.D.
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Roy D. Baynes, M.D., Ph.D.
Dr. Roy D. Baynes, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
-100.00%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Benjamin Thorner
Mr. Benjamin Thorner
Chief Business Officer, General Counsel
Chief Business Officer, General Counsel
--
--
Dr. Leon Chen, Ph.D.
Dr. Leon Chen, Ph.D.
Director
Director
--
--
Mr. Robert Huffines
Mr. Robert Huffines
Independent Director
Independent Director
--
--
Mr. David Meline
Mr. David Meline
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
111.11K
+100.00%
,
,
--
--
Dr. Alfred Bowie, Ph.D.
Dr. Alfred Bowie, Ph.D.
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Roy D. Baynes, M.D., Ph.D.
Dr. Roy D. Baynes, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
-100.00%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Chief Operating Officer
Chief Operating Officer
--
--

常见问题

Eikon Therapeutics Ord Shs的前五大股东是谁?

Eikon Therapeutics Ord Shs 的前五大股东如下:Dr. Roger M. Perlmutter, M.D., Ph.D.